NEUROLOGY 1993;43:1313
© 1993 American Academy of Neurology
Stroke associated with ephedrine use
Askiel Bruno, MD,
Kurt B. Nolte, MD and
John Chapin, MD
Neurology Service, Veterans Affairs Medical Center, and the Department of Neurology (Drs. Bruno and Chapin), University of New Mexico School of Medicine, and the Office of the Medical Investigator and Department of Pathology (Dr. Nolte), University of New Mexico School of Medicine, Albuquerque, NM.
Several sympathomimetic agents have been associated with ischemic and hemorrhagic stroke. Ephedrine, a sympathomimetic drug that has a high potential for abuse and can be readily obtained without a prescription in unrestricted quantities, has rarely been associated with stroke. We report ephedrine-related stroke in three patients. One patient developed a thalamic infarct after ingesting known quantities of ephedrine as street-purchased "speed" for weight loss. Two patients had fatal intracranial hemorrhages after ingesting unknown quantities of ephedrine; one of them had a history of drug abuse, and one lacked a history of ephedrine use or drug abuse. Ephedrine appears to predispose to both ischemic and hemorrhagic stroke. The mechanisms responsible for the different cerebrovascular complications remain to be proven. Restriction of ephedrine availability should be considered.
Address correspondence and reprint requests to Dr. Askiel Bruno, Neurology Service 127, 2100 Ridgecrest Drive SE, VA Hospital, Albuquerque, NM 87108.
Received August 12,1992. Accepted for publication in final form December 1,1992.
This article has been cited by other articles:
|
|
|
|
 
D Gupta and M D Nair
Neurogenic orthostatic hypotension: chasing "the fall"
Postgrad. Med. J.,
January 1, 2008;
84(987):
6 - 14.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Avois, N Robinson, C Saudan, N Baume, P Mangin, and M Saugy
Central nervous system stimulants and sport practice
Br. J. Sports Med.,
July 1, 2006;
40(suppl_1):
i16 - i20.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Singer, P. Sandroni, T. L. Opfer-Gehrking, G. A. Suarez, C. M. Klein, S. Hines, P. C. O'Brien, J. Slezak, and P. A. Low
Pyridostigmine Treatment Trial in Neurogenic Orthostatic Hypotension
Arch Neurol,
April 1, 2006;
63(4):
513 - 518.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.B. Morgenstern, C.M. Viscoli, W.N. Kernan, L.M. Brass, J.P. Broderick, E. Feldmann, J.L. Wilterdink, T. Brott, and R.I. Horwitz
Use of Ephedra-containing products and risk for hemorrhagic stroke
Neurology,
January 14, 2003;
60(1):
132 - 135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Samenuk, M. S. Link, M. K. Homoud, R. Contreras, T. C. Theohardes, P. J. Wang, and N. A. M. Estes III
Adverse Cardiovascular Events Temporally Associated With Ma Huang, an Herbal Source of Ephedrine
Mayo Clin. Proc.,
January 1, 2002;
77(1):
12 - 16.
[Abstract]
[PDF]
|
|
|
|
|
|
|
C. A. Haller and N. L. Benowitz
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
N. Engl. J. Med.,
December 21, 2000;
343(25):
1833 - 1838.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Bowyer, G. D. Newport, W. Slikker Jr., B. Gough, S. A. Ferguson, and J. Tor-Agbidye
An Evaluation of l-Ephedrine Neurotoxicity with Respect to Hyperthermia and Caudate/Putamen Microdialysate Levels of Ephedrine, Dopamine, Serotonin, and Glutamate
Toxicol. Sci.,
May 1, 2000;
55(1):
133 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K VAHEDI, V DOMIGO, P AMARENCO, and M-G BOUSSER
Ischaemic stroke in a sportsman who consumed MaHuang extract and creatine monohydrate for body building
J. Neurol. Neurosurg. Psychiatry,
January 1, 2000;
68(1):
112 - 113.
[Full Text]
|
|
|
|
